Olympiad Research’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Olympiad Research’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,427	Closed	-$2.52M	–	345
2022 Q2	$2.52M	Buy	+33,427	New	+$1.49M	1.13%	26

Olympiad Research's TPTX Position: Q3 2022 in Review

Olympiad Research sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 33,427 shares — an estimated $2.52M sold.

Olympiad Research first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $2.52M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Olympiad Research reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Olympiad Research sold 33,427 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.52M.
Olympiad Research first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Olympiad Research's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.52M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Olympiad Research's 13F filing for Q3 2022, filed 7 Nov 2022.